Literature DB >> 16880438

Autoimmunity against eye-muscle antigens may explain thyroid-associated ophthalmopathy.

Junichi Tani1, Jack R Wall.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16880438      PMCID： PMC1513432          DOI： 10.1503/cmaj.051680

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  3 in total

1.  Extraocular muscle is defined by a fundamentally distinct gene expression profile.

Authors:  J D Porter; S Khanna; H J Kaminski; J S Rao; A P Merriam; C R Richmonds; P Leahy; J Li; F H Andrade
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-25       Impact factor: 11.205

2.  Gene expression profiling of orbital adipose tissue from patients with Graves' ophthalmopathy: a potential role for secreted frizzled-related protein-1 in orbital adipogenesis.

Authors:  Seema Kumar; Alexey Leontovich; Michael J Coenen; Rebecca S Bahn
Journal:  J Clin Endocrinol Metab       Date:  2005-05-10       Impact factor: 5.958

3.  Serum antibodies to collagen XIII: a further good marker of active Graves' ophthalmopathy.

Authors:  A De Bellis; D Sansone; C Coronella; M Conte; S Iorio; S Perrino; M Battaglia; G Bellastella; J R Wall; A Bellastella; A Bizzarro
Journal:  Clin Endocrinol (Oxf)       Date:  2005-01       Impact factor: 3.478
  3 in total
  5 in total

1.  Biomarker identification of thyroid associated ophthalmopathy using microarray data.

Authors:  Hong-Bin Yang; Jie Jiang; Lu-Lu Li; Huang-Qiang Yang; Xiao-Yu Zhang
Journal:  Int J Ophthalmol       Date:  2018-09-18       Impact factor: 1.779

2.  Immunohistochemical studies using immunized Guinea pig sera with features of anti-human thyroid, eye and skeletal antibody and Graves' sera.

Authors:  Ildikó Molnár; Zita Szombathy; Ilona Kovács; A József Szentmiklósi
Journal:  J Clin Immunol       Date:  2007-01-23       Impact factor: 8.317

3.  99Tcm-octreotide scintigraphy and serum eye muscle antibodies in evaluation of active thyroid-associated ophthalmopathy.

Authors:  B Sun; Z Zhang; C Dong; Y Zhang; C Yan; S Li
Journal:  Eye (Lond)       Date:  2017-04-07       Impact factor: 3.775

4.  Pathogenesis of thyroid-associated ophthalmopathy: does autoimmunity against calsequestrin and collagen XIII play a role?

Authors:  Hooshang Lahooti; Kishan R Parmar; Jack R Wall
Journal:  Clin Ophthalmol       Date:  2010-05-14

5.  Update on the medical treatment of Graves' ophthalmopathy.

Authors:  Gregory J Griepentrog; James A Garrity
Journal:  Int J Gen Med       Date:  2009-12-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.